publicaciones seleccionadas documento HSD105 Cost Savings Benefits of Operational Waste Minimization in a Care Program by Cohorts of Babies on Treatment With Palivizumab Impact of a Pharmacotherapeutic Follow-Up Program on the Cost-Month-Patient, Stratified By Risk-Pharmacological Type
R Herrera
|
Persona
